Vishwas Setia

No open positions remaining

Net worth: 10 M $ as of 31/05/2026

39 year

35 connections

Consumer Services

Finance

Health Technology

Profile

Vishwas Setia worked as an Investment Banking Summer Associate at Merrill Lynch & Co., Inc. in 2013.
Mr. Setia also worked as Chief Financial Officer at MapLight Therapeutics, Inc. from 2024 to 2026.
Mr. Setia completed an MBA degree at Kellogg School of Management in 2014 and holds an undergraduate degree from Delhi College of Engineering.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
MAPLIGHT THERAPEUTICS, INC. 0.84%	06/05/2026	356,256 ( 0.84% )	10 M $	31/05/2026

Former positions of Vishwas Setia

Companies	Position	End
MAPLIGHT THERAPEUTICS, INC.	Director of Finance/CFO	18/06/2026
Merrill Lynch & Co., Inc. /Old/ Merrill Lynch & Co., Inc. /Old/ Investment Banks/BrokersFinance Provides wealth management, securities trading and sales, corporate finance and investment banking services	Corporate Officer/Principal	01/08/2013

See the detail of Vishwas Setia's experience

Training of Vishwas Setia

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Vishwas Setia's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Merrill Lynch & Co., Inc. /Old/ Merrill Lynch & Co., Inc. /Old/ Investment Banks/BrokersFinance Provides wealth management, securities trading and sales, corporate finance and investment banking services	Finance
Delhi College of Engineering Delhi College of Engineering Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Kellogg School of Management Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
MapLight Therapeutics, Inc. MapLight Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics for debilitating central nervous system disorders	Health Technology